The Study of Jian Pi Yi Shen Hua Tan Granules in Cognitive Impairment After Acute Cerebral Infarction
Launched by DONGFANG HOSPITAL BEIJING UNIVERSITY OF CHINESE MEDICINE · Dec 25, 2015
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
The present study is designed to observe the symptoms,syndrome characteristics and neuropsychological changes of patients with cognitive dysfunction after Acute Cerebral Infarction, as well as study the patterns of syndrome evolution and neuropsychological characteristics, in order to provide evidences for the early-stage identification, diagnosis, intervention and treatment based on syndrome differentiation.
To assess the effectiveness of applying early-stage prevention on patients with cognitive impairment after Acute Cerebral Infarction through the use of traditional Chinese medicine--J...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients conform to the diagnostic criteria of acute ischemic stroke Online Certificate Status Protocol classification of cerebral infarction : Partial Anterior Circulation Infarct, Posterior Circulation Infarct or Lacunar Infarction - Stroke onset within 14 days
- • Neuropsychological assessments: Montreal Cognitive Assessment Scale scores less than 26 points or scores less than 27 points,MMSE scores range from 19 points to 26 points
- • Age from forty to eighty, gender not limited
- • Informed and signed the informed consent
- Exclusion Criteria:
- • Transient Ischemic Attack
- • Online Certificate Status Protocol classification of cerebral infarction is a total anterior circulation infarction
- • Stroke patients with the causes of cerebral hemorrhage, subarachnoid hemorrhage, brain tumors, brain injury, or blood diseases and so on.
- • Stroke with an onset of more than 14 days
- • Cerebral embolism caused by atrial fibrillation resulted from rheumatic heart disease, coronary heart disease and other heart diseases.
- • Patients who cannot cooperate with the check due to serious visual, hearing dysfunction, apraxia, aphasia.
- • Patients with other neurological diseases which can affect cognitive function (for example: severe Parkinson's disease, normal pressure hydrocephalus, brain tumors, encephalitis)
- • Patients with communication difficulties, or psychiatric disease
- • Depression (Hamilton Depression Scale scores more than or equal to 17 points) Diagnosed with alcohol or drug dependence within the past six months
- • With other diseases which can cause cognitive dysfunction, Such as thyroid dysfunction, severe anemia, syphilis, Human Immunodeficiency Virus and so on
- • With a previous history of stroke and serious sequelae, and cannot cope with neuropsychological examination
- • With severe primary diseases, and cannot comply with the above scheme
About Dongfang Hospital Beijing University Of Chinese Medicine
Dongfang Hospital, affiliated with Beijing University of Chinese Medicine, is a leading institution in the field of traditional Chinese medicine and integrative healthcare. With a commitment to advancing medical research and clinical practices, the hospital plays a pivotal role in conducting clinical trials that explore innovative treatment modalities and their efficacy. The institution is dedicated to enhancing patient care through rigorous scientific investigation and collaboration with national and international research communities, ensuring that its findings contribute to the global understanding of health and wellness.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Beijing, Beijing, China
Chongqing, Chongqing, China
Jiangmen, Guangdong, China
Changchun, Jilin, China
Patients applied
Trial Officials
Yunling Zhang, PhD,MD
Study Chair
Dongfang Hospital Beijing University of Chinese Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials